Scorpius Holdings, Inc.
Biotechnology · Healthcare
William Ostrander
Scorpius Holdings, Inc.
Equibles does not estimate personal net worth.
About William Ostrander
Scorpius Holdings, Inc. reported in an 8-K filed April 8, 2026 that William Ostrander resigned as Chief Financial Officer, effective March 31, 2026. Scorpius Holdings, Inc. is classified in the Biotechnology industry within the Healthcare sector.
“On March 29, 2026, William Ostrander, the Chief Financial Officer of Scorpius Holdings, Inc., a Delaware corporation (the "Company"), notified the Company of his decision to resign, effective March 31, 2026, from his position as the Company's Chief Financial Officer.”
Affiliation history
-
Scorpius Holdings, Inc.
Proxy statement
CurrentStart not stated–present
Last confirmed July 27, 2020
-
Scorpius Holdings, Inc.
CFO
SEC 8-K
2021-01-04–2026-03-31